Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Katherine Y. Look, MD
Indiana University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ncic-Clinical Trials Group
Kingston, Ontario, Canada
- University of Alabama Comprehensive Cancer Center
Birmingham, Alabama, United States
- Ccop - Greater Phoenix
Phoenix, Arizona, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center
Orange, California, United States
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Rush-Presbyterian-St. Luke'S Medical Center
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Radiation Oncology Branch
Bethesda, Maryland, United States
- Tufts University School of Medicine
Boston, Massachusetts, United States
- University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Ccop - Southern Nevada Cancer Research Foundation
Las Vegas, Nevada, United States
- Cooper Hospital/university Medical Center
Camden, New Jersey, United States
- Cancer Center of Albany Medical Center
Albany, New York, United States
- State University of New York Health Science Center at Brooklyn
Brooklyn, New York, United States
- Lineberger Comprehensive Cancer Center, Unc
Chapel Hill, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
- Barrett Cancer Center, the University Hospital
Cincinnati, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, United States
- University of Oklahoma College of Medicine
Oklahoma City, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Kimmel Cancer Center of Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Ccop - Upstate Carolina
Spartanburg, South Carolina, United States
- Simmons Cancer Center - Dallas
Dallas, Texas, United States
- University of Washington Medical Center
Seattle, Washington, United States
- Tacoma General Hospital
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 1998
- Primary completion
- 30 Apr 2004
- Completion
- —
- Last update posted
- 11 Apr 2013
- Registered enrollment
- —
- Registry id
- NCT00003316
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.